US Patent Class 424
DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS
 Electronic File Wrappers |  Electronic Patent Documents |  Paper Patent Documents | Current as of: June, 1999
|  and Services |
| Electronic File Wrappers | Electronic Patent Documents | Paper Patent Documents | Current as of: June, 1999
| and Services |
| DF | CLASS NOTES | |
| 1.11 | DF | RADIONUCLIDE OR INTENDED RADIONUCLIDE CONTAINING; ADJUVANT OR CARRIER COMPOSITIONS; INTERMEDIATE OR PREPARATORY COMPOSITIONS |
| 1.13 | DF | .~ In aerosol, fine spray, effervescent, pressurized fluid, vapor or gas, or complete composition therefor |
| 1.17 | DF | .~ Attached to or within viable or inviable whole micro-organism, cell, virus, fungus or specified sub-cellular structure thereof (e.g., platelet, red blood cell) |
| 1.21 | DF | .~ Molecular bilayer structure (e.g., vesicle, liposome) |
| 1.25 | DF | .~ Dissolving or eluting from solid or gel matrix (e.g., capsule, tablet) |
| 1.29 | DF | .~ Coated, impregnated, or colloidal particulate (e.g., microcapsule, micro-sphere, micro-aggregate, macro-aggregate) |
| 1.33 | DF | .~.~ Delivery to active site involves particle dissolving, degrading, or otherwise releasing of radionuclide |
| 1.37 | DF | .~.~ Radionuclide or intended radionuclide in an organic compound |
| 1.41 | DF | .~ Attached to lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interferon, interleukin, macrophage factor, colony stimulating factor, erythropoietin); derivative thereof |
| 1.45 | DF | .~ Attached to cyclopentano-hydrophenanthrene (e.g., cholesterol, bile acid, steroids, cholane), hormone, or neurotransmitter, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., T3, T4, insulin, human chorionic gonadotropin, intragonadal regulatory protein, Mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine); derivative thereof |
| 1.49 | DF | .~ Attached to antibody or antibody fragment or immunoglobulin; derivative |
| 1.53 | DF | .~.~ Attachment via an added element (e.g., bifunctional compound or coordinate, coupling agent, spacer compound, bridging compound, conjugated chelate) |
| 1.57 | DF | .~ Attached to antigen or hapten; derivative thereof |
| 1.61 | DF | .~ In an inorganic compound |
| 1.65 | DF | .~ In an organic compound |
| 1.69 | DF | .~.~ Attached to peptide or protein of 2+ amino acid units (e.g., dipeptide, folate, fibrinogen, transferrin, sp. enzymes); derivative thereof |
| 1.73 | DF | .~.~ Attached to carbohydrate compound; derivative thereof (e.g., DNA, nucleotide, nucleoside, sugar, starch, tannin, saccharide, polysaccharide, cellulose, O-, N- and S-glycoside, vitamin B12) |
| 1.77 | DF | .~.~ Phosphorus-containing organic compound |
| 1.81 | DF | .~.~ Nonmetal radionuclide or intended radionuclide (e.g., carbon) |
| 1.85 | DF | .~.~.~ Halogen |
| 1.89 | DF | .~.~.~.~ Fluorine |
| 9.1 | DF | IN VIVO DIAGNOSIS OR IN VIVO TESTING |
| 9.2 | DF | .~ Testing efficacy or toxicity of a compound or composition (e.g., drug, vaccine, etc.) |
| 9.3 | DF | .~ Magnetic imaging agent (e.g., NMR, MRI, MRS, etc.) |
| 9.31 | DF | .~.~ Clay or zeolite containing |
| 9.32 | DF | .~.~ Particle containing a transition, actinide, or lanthanide metal (e.g., hollow or solid particle, granule, etc.) |
| 9.321 | DF | .~.~.~ Liposome |
| 9.322 | DF | .~.~.~ Polymer containing (e.g., polypeptide, synthetic resin, etc.) |
| 9.323 | DF | .~.~.~.~ Metal is paramagnetic |
| 9.33 | DF | .~.~ Nitroxide or nitroxide containing |
| 9.34 | DF | .~.~ Polypeptide attached to or complexed with the agent (e.g., protein, antibody, etc.) |
| 9.341 | DF | .~.~.~ The region of the imaging agent responsible for binding to an in vivo target or the region of the target responsible for binding to the agent is specifically recited functionally or as a sequence of amino acids, carbohydrate residues, or nucleic acids |
| 9.35 | DF | .~.~ Carbohydrate or derivative thereof attached to or complexed with the agent |
| 9.351 | DF | .~.~.~ The region of the imaging agent responsibile for binding to an in vivo target or the region of the target responsible for binding to the agent is specifically recited functionally or as a sequence of amino acids, carbohydrate residues, or nucleic acids |
| 9.36 | DF | .~.~ Transition, actinide, or lanthanide metal containing |
| 9.361 | DF | .~.~.~ Heterocyclic compound is attached to or complexed with the metal |
| 9.362 | DF | .~.~.~.~ Porphyrin or derivative thereof |
| 9.363 | DF | .~.~.~.~ Hetero ring contains at least eight members |
| 9.364 | DF | .~.~.~ Polyamino-polycarbonyl moiety attached to or complexed with the metal |
| 9.365 | DF | .~.~.~.~ Contains at least one -C(=O)-N- group |
| 9.37 | DF | .~.~ Imageable halogen containing |
| 9.4 | DF | .~ X-ray contrast imaging agent (e.g., computed tomography, angiography, etc.) |
| 9.41 | DF | .~.~ Barium containing |
| 9.411 | DF | .~.~.~ Polymer containing (e.g., polypeptide, synthetic resin, etc.) |
| 9.42 | DF | .~.~ Transition, actinide, or lanthanide metal containing |
| 9.43 | DF | .~.~ Carbohydrate or derivative thereof attached to or complexed with the agent |
| 9.44 | DF | .~.~ Hetero ring containing |
| 9.45 | DF | .~.~ Halogenated benzene ring containing |
| 9.451 | DF | .~.~.~ Two or more halogenated benzene rings in the same compound |
| 9.452 | DF | .~.~.~.~ Three or more amide groups are attached directly to the same benzene ring by nonionic bonding |
| 9.453 | DF | .~.~.~.~ Carbonyl of a carboxylic acid or salt thereof attached directly to the benzene ring |
| 9.454 | DF | .~.~.~ Three or more amide groups are attached directly to the same benzene ring by nonionic bonding |
| 9.455 | DF | .~.~.~ Carbonyl of a carboxylic acid or salt thereof attached directly to the benzene ring |
| 9.5 | DF | .~ Ultrasound contrast agent |
| 9.51 | DF | .~.~ Liposome containing |
| 9.52 | DF | .~.~ Stable gas bubbles containing or intentional solubilized gas containing |
| 9.6 | DF | .~ Diagnostic or test agent produces in vivo fluorescence |
| 9.61 | DF | .~.~ Porphyrin or derivative thereof |
| 9.7 | DF | .~ Diagnostic or test agent produces visible change in mouth |
| 9.71 | DF | .~.~ Plaque detection |
| 9.8 | DF | .~ Diagnostic or test agent produces visible change on skin |
| 9.81 | DF | .~.~ Visible immune reaction (e.g., allergy testing, etc.) |
| 10.1 | DF | IDENTIFICATION OR WARNING FEATURE |
| 10.2 | DF | .~ Printed or embossed unitary dosage form |
| 10.3 | DF | .~ Color or color change feature |
| 10.31 | DF | .~.~ Combined with animal or insect repellant or insecticide (e.g., shark, fish, roach, etc.) |
| 10.32 | DF | .~.~ Combined with ophthalmic or dentifrice preparation |
| 10.4 | DF | .~ Taste or smell or chemical irritation to the eye, nose, or mouth feature |
| 40 | DF | COMBUSTIBLE OR CHEMICALLY REACTIVE TO PRODUCE A SMOKE, MIST OR AEROSOL |
| 41 | DF | .~ Elemental sulfur containing |
| 42 | DF | .~ Nitrate containing |
| 400 | DF | PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM |
| 401 | DF | .~ Cosmetic, antiperspirant, dentifrice |
| 402 | DF | .~ Wearing apparel, fabric, or cloth |
| 403 | DF | .~.~ Insect repellent or mothproofed |
| 404 | DF | .~.~ Antifungal or antibacterial |
| 405 | DF | .~ Biocides; animal or insect repellents or attractants (e.g., disinfectants, pesticides, etc.) |
| 406 | DF | .~.~ Ingredients for reducing the noxious effect of the active substances to organisms other than pest (e.g., toxicity reducing compositions, self-destructing compositions, etc.) |
| 407 | DF | .~.~ Containing material to enhance the sticking of the active ingredients |
| 408 | DF | .~.~ Capsule or pelleted or tablet |
| 409 | DF | .~.~ Solid as carrier or diluent |
| 410 | DF | .~.~.~ Impregnated or coated food or edible simulative of food (e.g., bait, poison, etc.) |
| 411 | DF | .~.~.~ Impregnated or coated nominal articles (e.g., flea collars, etc.) |
| 412 | DF | .~.~.~.~ Packaging, cordage building material or container |
| 413 | DF | .~.~.~.~.~ Cellulosic material or building material |
| 414 | DF | .~.~.~ Impregnated or coated paper or foil |
| 415 | DF | .~.~.~.~ Wrapping paper |
| 416 | DF | .~.~.~.~ Insecticidal paper or foil |
| 417 | DF | .~.~.~ Coated particulate form (e.g., liposome, etc.) |
| 418 | DF | .~.~.~.~ Protein or derivative or polysaccharide or derivative |
| 419 | DF | .~.~.~.~ Natural or synthetic resin |
| 420 | DF | .~.~.~.~ Waxes, fatty acids, etc. (e.g., liposome, etc.) |
| 421 | DF | .~.~.~.~ Inorganic particle |
| 422 | DF | .~ Implant or insert |
| 423 | DF | .~.~ Surgical implant or material |
| 424 | DF | .~.~.~ Membrane or diffusion barrier |
| 425 | DF | .~.~.~.~ Diffusion barrier is matrix |
| 426 | DF | .~.~.~ Errodable, resorbable, or dissolving |
| 427 | DF | .~.~ Ocular |
| 428 | DF | .~.~.~ Bioerrodable, resorbable, or dissolving |
| 429 | DF | .~.~.~ Contact lens |
| 430 | DF | .~.~ Vaginal, urethral, uterine |
| 431 | DF | .~.~.~ Tampon |
| 432 | DF | .~.~.~ IUD or ring |
| 433 | DF | .~.~.~ Depot, pellet, matrix, or suppository |
| 434 | DF | .~.~ Mucosal (e.g., nasal, etc.) |
| 435 | DF | .~.~.~ Mouth |
| 436 | DF | .~.~.~ Anal, rectal (e.g., suppositories, etc.) |
| 437 | DF | .~.~ Otic |
| 438 | DF | .~ Specially adapted for ruminant animal |
| 439 | DF | .~ Food or edible as carrier for pharmaceutical |
| 440 | DF | .~.~ Candy, candy coated or chewing gum |
| 441 | DF | .~.~ Chewable tablet or wafer |
| 442 | DF | .~.~ Animal food |
| 443 | DF | .~ Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments |
| 444 | DF | .~.~ Resorbable by the body |
| 445 | DF | .~.~ Dressings |
| 446 | DF | .~.~.~ Medicated gauze pads |
| 447 | DF | .~.~ Bandages with incorporated medicaments |
| 448 | DF | .~.~.~ Pressure sensitive adhesive means |
| 449 | DF | .~.~.~ Transdermal or percutaneous |
| 450 | DF | .~ Liposomes |
| 451 | DF | .~ Capsules (e.g., of gelatin, of chocolate, etc.) |
| 452 | DF | .~.~ With claimed designated perfecting feature in contents (e.g., excipient, lubricant, etc.) |
| 453 | DF | .~.~ Telescoping two piece |
| 454 | DF | .~.~.~ With tamperproof, locking, or sealing feature |
| 455 | DF | .~.~ Containing emulsions, dispersions, or solutions |
| 456 | DF | .~.~ Gelatin |
| 457 | DF | .~.~ Sustained or differential release |
| 458 | DF | .~.~.~ Containing discrete coated particles pellets, granules, or beads |
| 459 | DF | .~.~.~.~ Organic coatings |
| 460 | DF | .~.~.~.~.~ Containing proteins or derivatives thereof (e.g., gelatin, etc.) |
| 461 | DF | .~.~.~.~.~ Containing polysaccharide (e.g., cellulose sugars, etc.) |
| 462 | DF | .~.~.~.~.~ Containing solid synthetic polymers |
| 463 | DF | .~.~ Coated capsules |
| 464 | DF | .~ Tablets, lozenges, or pills |
| 465 | DF | .~.~ With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.) |
| 466 | DF | .~.~ Effervescent |
| 467 | DF | .~.~ Printed, embossed, grooved, or perforated |
| 468 | DF | .~.~ Sustained or differential release type |
| 469 | DF | .~.~.~ Discrete particles in supporting matrix |
| 470 | DF | .~.~.~.~ Where particles are granulated |
| 471 | DF | .~.~.~ Plural concentric cores |
| 472 | DF | .~.~.~ Layered unitary dosage forms |
| 473 | DF | .~.~.~.~ With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.) |
| 474 | DF | .~.~ Coated pills or tablets |
| 475 | DF | .~.~.~ Organic coatings |
| 476 | DF | .~.~.~.~ Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof (e.g., chocolate) |
| 477 | DF | .~.~.~.~ Containing proteins or derivatives thereof |
| 478 | DF | .~.~.~.~.~ Gelatin containing |
| 479 | DF | .~.~.~.~ Containing polysaccharide (e.g., sugar, etc.) |
| 480 | DF | .~.~.~.~.~ Cellulose or derivative |
| 481 | DF | .~.~.~.~ Containing natural gums or resins |
| 482 | DF | .~.~.~.~ Containing solid synthetic polymers |
| 483 | DF | .~.~.~ Ion-exchange resins |
| 484 | DF | .~ Matrices |
| 485 | DF | .~.~ Natural gums, resin or latex |
| 486 | DF | .~.~ Synthetic polymer |
| 487 | DF | .~.~.~ Acrylic acid and derivatives |
| 488 | DF | .~.~ Polysaccharides (e.g., cellulose, etc.) |
| 489 | DF | .~ Particulate form (e.g., powders, granules, beads, microcapsules, and pellets) |
| 490 | DF | .~.~ Coated (e.g., microcapsules) |
| 491 | DF | .~.~.~ Containing proteins and derivatives |
| 492 | DF | .~.~.~.~ Gelatin |
| 493 | DF | .~.~.~ Containing polysaccharides (e.g., sugars) |
| 494 | DF | .~.~.~.~ Cellulose derivatives |
| 495 | DF | .~.~.~.~.~ Ethyl cellulose |
| 496 | DF | .~.~.~ Containing natural gums/resins |
| 497 | DF | .~.~.~ Containing solid synthetic polymers |
| 498 | DF | .~.~.~ Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof |
| 499 | DF | .~.~ Contains proteins or derivative or polysaccharides or derivative |
| 500 | DF | .~.~ Contains natural gums and resins |
| 501 | DF | .~.~ Contains solid synthetic resin |
| 502 | DF | .~.~ Contains waxes, higher fatty acids, higher fatty alcohols |
| 43 | DF | EFFERVESCENT OR PRESSURIZED FLUID CONTAINING |
| 44 | DF | .~ Gas produced in situ by chemical reaction |
| 45 | DF | .~ Organic pressurized fluid (e.g., freons, etc.) |
| 46 | DF | .~.~ Powder or dust containing |
| 47 | DF | .~.~ Topical live body grooming or adorning aid (e.g., hair spray, antiperspirant, etc.) |
| 48 | DF | CHEWING GUM TYPE |
| 49 | DF | DENTIFRICES (includes mouth wash) |
| 50 | DF | .~ Ferment containing (e.g., enzymes, bacteria, etc.) |
| 51 | DF | .~ Iodine or iodine compound containing |
| 52 | DF | .~ Fluorine or fluorine compound containing |
| 53 | DF | .~ Oxygen or chlorine releasing compound containing |
| 54 | DF | .~ Ammonia, amine, or derivative thereof (e.g., urea, etc.) |
| 55 | DF | .~ Hydroxy carboxylic acid or derivative thereof (e.g., methyl salicylate, etc.) |
| 56 | DF | .~ Organic sulfate or sulfonate containing |
| 57 | DF | .~ Phosphate compound containing |
| 58 | DF | .~ Plant extract of undetermined constitution |
| 59 | DF | TOPICAL SUN OR RADIATION SCREENING, OR TANNING PREPARATIONS |
| 60 | DF | .~ Aromatic acid or derivative containing (e.g., aminobenzoic acid or methyl salicylate, etc.) |
| 61 | DF | MANICURE OR PEDICURE COMPOSITIONS |
| 62 | DF | BLEACH FOR LIVE HAIR OR SKIN (E.G., PEROXIDES, ETC.) |
| 63 | DF | LIVE SKIN COLORANT CONTAINING |
| 64 | DF | .~ Lip |
| 65 | DF | ANTI-PERSPIRANTS OR PERSPIRATION DEODORANTS |
| 66 | DF | .~ Zirconium compound containing |
| 67 | DF | .~ Zinc compound containing |
| 68 | DF | .~ Aluminum compound containing |
| 69 | DF | FACE OR BODY POWDERS FOR GROOMING, ADORNING, OR ABSORBING |
| 70.1 | DF | LIVE HAIR OR SCALP TREATING COMPOSITIONS (NONTHERAPEUTIC) |
| 70.2 | DF | .~ Permanent waving or straightening |
| 70.4 | DF | .~.~ Metal salt containing |
| 70.5 | DF | .~.~ Sulfur compound containing |
| 70.51 | DF | .~.~.~ Cysteine, cysteamine, or derivatives thereof |
| 70.6 | DF | .~ Hair coloring (nondyeing) |
| 70.7 | DF | .~.~ Mascara |
| 70.8 | DF | .~ Astringent or sebum inhibiting |
| 70.9 | DF | .~ UV protectant |
| 70.11 | DF | .~ Polymer containing (nonsurfactant, natural or synthetic) |
| 70.12 | DF | .~.~ Silicon containing |
| 70.121 | DF | .~.~.~ Silsesquioxanes |
| 70.122 | DF | .~.~.~ Amino or amido containing |
| 70.13 | DF | .~.~ Polysaccharide or derivative |
| 70.14 | DF | .~.~ Protein or derivative |
| 70.15 | DF | .~.~ Polyvinylpyrrolidone or copolymer thereof |
| 70.16 | DF | .~.~ Poly(meth)acrylic acid, salt, or copolymer thereof |
| 70.17 | DF | .~.~ Polyamine, polyamide, or derivatives thereof |
| 70.19 | DF | .~ Two or more designated surfactant containing |
| 70.21 | DF | .~ Amphoteric or zwitterionic surfactant containing |
| 70.22 | DF | .~ Anionic surfactant containing |
| 70.23 | DF | .~.~ Phosphorous containing |
| 70.24 | DF | .~.~ Sulfur containing (sulfates, sulfonates, etc.) |
| 70.27 | DF | .~ Cationic surfactant containing |
| 70.28 | DF | .~.~ Quaternary ammonium salts |
| 70.31 | DF | .~ Nonionic surfactant containing |
| 73 | DF | .~ Shaving preparation |
| 74 | DF | .~ Plant extract of undetermined constitution |
| 75 | DF | EMBALMING OR UNDERTAKING COMPOSITIONS |
| 76.1 | DF | DEODORANTS (NONBODY) |
| 76.2 | DF | .~ Deodorizing substance is evaporable sublimable or gas (e.g., deodorization of air, aerosol spray compositions, etc.) |
| 76.21 | DF | .~.~ For chemical reaction with odor producing material or gas evolving composition |
| 76.3 | DF | .~.~ From a gel or solid matrix (e.g., retarded vaporization compositions, etc.) |
| 76.4 | DF | .~.~.~ With odor masking substances (e.g., perfumes, etc.) |
| 76.5 | DF | .~ For application to waste materials, solid or liquid refuse or sewage |
| 76.6 | DF | .~.~ Waste includes fecal material or urine (e.g., feed lot or cage waste, pet litter, etc.) |
| 76.7 | DF | .~.~.~ For toilet or urinal (e.g., recirculating toilet fluid, etc.) |
| 76.8 | DF | .~ With bio-affecting material (i.e., biocide or biostat) |
| 76.9 | DF | .~.~ Inorganic only or containing plant or animal extract |
| 77 | DF | ADHESIVE TRAPPING COMPOSITIONS |
| 78.01 | DF | DIGESTIVE SYSTEM REGULATOR CONTAINING SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI) (E.G., ANTI-DIARRHETIC, ANTICONSTIPATION, APPETITE SUPPRESSANT, LAXATIVE, ETC.): |
| 78.02 | DF | TOPICAL BODY PREPARATION CONTAINING SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI) |
| 78.03 | DF | .~ Skin cosmetic coating |
| 78.04 | DF | .~ Ophthalmic preparation |
| 78.05 | DF | .~ Anti-inflammatory or anti-irritant (e.g., anti-arthritic, etc.) |
| 78.06 | DF | .~ Skin burn or open wound treatment |
| 78.07 | DF | .~ Anti-infective |
| 78.08 | DF | SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI) |
| 78.09 | DF | .~ Anti-fouling composition (e.g., paints, etc.) |
| 78.1 | DF | .~ Ion exchange resin |
| 78.11 | DF | .~.~ Plural ion exchange resins |
| 78.12 | DF | .~.~ Adsorbate or treating agent contains nitrogen |
| 78.13 | DF | .~.~.~ Oxygen or sulfur heterocycle |
| 78.14 | DF | .~.~.~ Nitrogen heterocycle |
| 78.15 | DF | .~.~.~.~ Plural nitrogen heteroatoms or rings |
| 78.16 | DF | .~.~.~ Amine containing aromatic group |
| 78.17 | DF | .~ Aftertreated polymer (e.g., grafting, blocking, etc.) |
| 78.18 | DF | .~.~ Polymer derived from ethylenic monomers only |
| 78.19 | DF | .~.~.~ Heterocyclic monomer |
| 78.2 | DF | .~.~.~.~ Maleic anhydride monomer copolymerized with hydrocarbon monomer |
| 78.21 | DF | .~.~.~.~.~ Ring-opened product thereof |
| 78.22 | DF | .~.~.~.~ Nitrogen heterocycle |
| 78.23 | DF | .~.~.~.~.~ Six-membered ring |
| 78.24 | DF | .~.~.~.~.~ N-Vinyl-2-pyrrolidone |
| 78.25 | DF | .~.~.~.~.~.~ Complexed with molecular halogen or compound containing only halogen atoms |
| 78.26 | DF | .~.~.~ Chemical treating agent contains element other than C, H, O, alkali, or alkaline earth metal |
| 78.27 | DF | .~.~.~.~ Nitrogen or sulfur |
| 78.28 | DF | .~.~.~.~.~ Sulfur heterocycle |
| 78.29 | DF | .~.~.~.~.~ Nitrogen heterocycle |
| 78.3 | DF | .~.~ Heterocyclic monomer |
| 78.31 | DF | .~ Polymer from ethylenic monomers only |
| 78.32 | DF | .~.~ Heterocyclic monomer |
| 78.33 | DF | .~.~.~ Maleic anhydride monomer |
| 78.34 | DF | .~.~ Heavy metal containing monomer |
| 78.35 | DF | .~.~ Nitrogen or sulfur containing monomer |
| 78.36 | DF | .~ Nitrogen heterocycle |
| 78.37 | DF | .~ Monomer contains oxygen |
| 78.38 | DF | .~.~ Oxygen heterocycle |
| 84 | DF | BAITS, ATTRACTANTS, OR LURES (NON-FOOD) |
| 85.1 | DF | LYMPHOKINE |
| 85.2 | DF | .~ Interleukin |
| 85.4 | DF | .~ Interferon |
| 85.5 | DF | .~.~ Gamma or immune |
| 85.6 | DF | .~.~ Beta or fibroblast |
| 85.7 | DF | .~.~ Alpha or leukocyte |
| 130.1 | DF | IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL |
| 131.1 | DF | .~ Anti-idiotypic |
| 132.1 | DF | .~ Derived from transgenic multicellular eukaryote (e.g., plant, etc.) |
| 133.1 | DF | .~ Structurally-modified antibody, immunoglobulin, or fragment thereof (e.g., chimeric, humanized, CDR-grafted, mutated, etc.) |
| 134.1 | DF | .~.~ Antibody, immunoglobulin, or fragment thereof fused via peptide linkage to nonimmunoglobulin protein, polypeptide, or fragment thereof (i.e., antibody or immunoglobulin fusion protein or polypeptide) |
| 135.1 | DF | .~.~ Single chain antibody |
| 136.1 | DF | .~.~ Bispecific or bifunctional, or multispecific or multifunctional, antibody or fragment thereof |
| 137.1 | DF | .~ Binds specifically-identified oligosaccharide structure |
| 138.1 | DF | .~ Binds expression product or fragment thereof of cancer-related gene (e.g., oncogene, proto-oncogene, etc.) |
| 139.1 | DF | .~ Binds antigen or epitope whose amino acid sequence is disclosed in whole or in part (e.g., binds specifically-identified amino acid sequence, etc.) |
| 140.1 | DF | .~ Extracorporeal or ex vivo removal of antibodies or immune complexes (e.g., removal of autoantibodies, etc.); or extracorporeal or ex vivo removal of antigen by antibodies (e.g., removal of cancer cells from bone marrow by antibodies, etc.) |
| 141.1 | DF | .~ Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) |
| 142.1 | DF | .~.~ Human |
| 143.1 | DF | .~.~ Binds receptor |
| 144.1 | DF | .~.~.~ Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., NK cell, etc.) |
| 145.1 | DF | .~.~ Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, etc.); or binds serum protein, plasma protein (e.g., tPA, etc.), or fibrin |
| 146.1 | DF | .~.~ Binds enzyme |
| 147.1 | DF | .~.~ Binds virus or component thereof |
| 148.1 | DF | .~.~.~ Immunodeficiency virus |
| 149.1 | DF | .~.~.~ Hepatitis virus |
| 150.1 | DF | .~.~ Binds bacterium or component thereof or substance produced by said bacterium |
| 151.1 | DF | .~.~ Binds parasitic organism (i.e., parasitic protozoan, multicellular ectoparasite (e.g., flea, tick, mite, etc.), or multicellular endoparasite (e.g., parasitic worm, etc.)) or component thereof or substance produced by said parasitic organism |
| 152.1 | DF | .~.~ Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell |
| 153.1 | DF | .~.~.~ Hematopoietic cell |
| 154.1 | DF | .~.~.~.~ T lymphocytic cell (e.g., T cell, thymocyte, etc.) |
| 155.1 | DF | .~.~.~ Cancer cell |
| 156.1 | DF | .~.~.~.~ Antigen characterized by name or molecular weight |
| 157.1 | DF | .~ Derived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.) |
| 158.1 | DF | .~ Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, vascular permeability factor, etc.); or binds serum protein, plasma protein, fibrin, or enzyme |
| 159.1 | DF | .~ Binds virus or component thereof |
| 160.1 | DF | .~.~ Immunodeficiency virus |
| 161.1 | DF | .~.~ Hepatitis virus |
| 162.1 | DF | .~.~ Hog cholera virus |
| 163.1 | DF | .~ Binds antigens of multiple bacterial species (e.g., multivalent antiserum that binds antigens of multiple bacterial species, etc.) |
| 164.1 | DF | .~ Binds bacterium or component thereof or substance produced by said bacterium |
| 165.1 | DF | .~.~ Staphylococcus or Streptococcus (e.g., pneumococcus or Streptococcus pneumoniae, Streptococcus mutans, etc.) |
| 166.1 | DF | .~.~ Corynebacterium (e.g., Corynebacterium diphtheriae, etc.) |
| 167.1 | DF | .~.~ Clostridium (e.g., Clostridium tetani, etc.) |
| 168.1 | DF | .~.~ Mycobacterium |
| 169.1 | DF | .~.~ Escherichia |
| 170.1 | DF | .~.~ Pseudomonas |
| 171.1 | DF | .~ Binds allergen or component thereof |
| 172.1 | DF | .~ Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell (e.g., honey, etc.) |
| 173.1 | DF | .~.~ Hematopoietic cell |
| 174.1 | DF | .~.~ Cancer cell |
| 175.1 | DF | .~ Binds hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., drug, etc.) |
| 176.1 | DF | .~ Free from infectious agents (e.g., viruses or bacteria removed or inactivated, etc.) |
| 177.1 | DF | .~ Reduced antigenicity, reduced ability to bind complement, or reduced numbers of activated complement components (e.g., free from aggregated, denatured, fragmented, or polymerized immunoglobulins; free from proteolytic enzymes, etc.) |
| 178.1 | DF | CONJUGATE OR COMPLEX OF MONOCLONAL OR POLYCLONAL ANTIBODY, IMMUNOGLOBULIN, OR FRAGMENT THEREOF WITH NONIMMUNOGLOBULIN MATERIAL |
| 179.1 | DF | .~ Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.) |
| 180.1 | DF | .~.~ Conjugate includes potentiator or composition comprising conjugate includes potentiator |
| 181.1 | DF | .~.~ Conjugated to nonproteinaceous bioaffecting compound (e.g., conjugated to cancer-treating drug, etc.) |
| 182.1 | DF | .~ Conjugate includes potentiator; or composition comprising conjugate includes potentiator |
| 183.1 | DF | .~ Conjugated to proteinaceous toxin or fragment thereof (e.g., conjugated to diphtheria toxin, Pseudomonas exotoxin, ricin, gelonin, abrin, etc.) |
| 184.1 | DF | ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.) |
| 185.1 | DF | .~ Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
| 186.1 | DF | .~.~ Disclosed amino acid sequence derived from virus |
| 187.1 | DF | .~.~.~ Retroviridae (e.g., feline leukemia, etc.) |
| 188.1 | DF | .~.~.~.~ Immunodeficiency virus (e.g., HIV, etc.) |
| 189.1 | DF | .~.~.~ Hepatitis virus |
| 190.1 | DF | .~.~ Disclosed amino acid sequence derived from bacterium (e.g., Mycoplasma, Anaplasma, etc.) |
| 191.1 | DF | .~.~ Disclosed amino acid sequence derived from parasitic organism (e.g., Dirofilaria, Eimeria, Trichinella, etc.) |
| 192.1 | DF | .~ Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
| 193.1 | DF | .~ Conjugate or complex |
| 194.1 | DF | .~.~ Conjugated via claimed linking group, bond, or coupling agent |
| 195.11 | DF | .~.~ Conjugate or complex includes hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or fragment thereof |
| 196.11 | DF | .~.~ Conjugate or complex includes virus or componenet thereof |
| 197.11 | DF | .~.~ Conjugate or complex includes bacterium or component thereof or substance produced by said bacterium |
| 198.1 | DF | .~ Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
| 199.1 | DF | .~ Recombinant virus encoding one or more heterologous proteins or fragments thereof |
| 200.1 | DF | .~ Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
| 201.1 | DF | .~ Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
| 202.1 | DF | .~ Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
| 203.1 | DF | .~ Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
| 204.1 | DF | .~ Virus or component thereof |
| 205.1 | DF | .~.~ Reassortant or deletion mutant virus |
| 206.1 | DF | .~.~.~ Influenza virus |
| 207.1 | DF | .~.~ Retroviridae (e.g., feline leukemia virus, bovine leukemia virus, avian leukosis virus, equine infectious anemia virus, Rous sarcoma virus, HTLV-I, etc.) |
| 208.1 | DF | .~.~.~ Immunodeficiency virus (e.g., HIV, etc.) |
| 209.1 | DF | .~.~ Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.) |
| 210.1 | DF | .~.~.~ Subunit vaccine containing hemagglutinin or neuraminidase |
| 211.1 | DF | .~.~ Paramyxoviridae (e.g., parainfluenza virus, respiratory syncytial virus, rinderpest virus, Sendai virus, canine tracheobronchitis virus, turkey rhinotracheitis virus, etc.) |
| 212.1 | DF | .~.~.~ Measles virus or mumps virus |
| 213.1 | DF | .~.~.~ Canine distemper virus |
| 214.1 | DF | .~.~.~ Newcastle disease virus |
| 215.1 | DF | .~.~ Reoviridae (e.g., rotavirus, reovirus, orbivirus, avian proventriculitis virus, bluetongue virus, Colorado tick fever virus, etc.) |
| 216.1 | DF | .~.~ Calciviridae or picornaviridae, except hepatitis A virus (e.g., foot-and- mouth disease virus (FMDV), coxsackievirus, echovirus, avian encephalomyelitis virus, Mengovirus, etc.) |
| 217.1 | DF | .~.~.~ Poliovirus |
| 218.1 | DF | .~.~ Togaviridae or Flaviviridae, except hepatitis C virus (e.g., yellow fever virus, bovine viral diarrhea virus, dengue virus, equine viral arteritis virus, equine encephalitis virus, Japanese B encephalitis virus, Sindbis virus, flavivirus, etc.) |
| 219.1 | DF | .~.~.~ Rubella virus |
| 220.1 | DF | .~.~.~ Hog cholera virus |
| 221.1 | DF | .~.~ Coronaviridae (e.g., neonatal calf diarrhea virus, feline infectious peritonitis virus, canine coronavirus, etc.) |
| 222.1 | DF | .~.~.~ Infectious bronchitis virus (IBV) |
| 223.1 | DF | .~.~.~ Transmissible gastroenteritis virus (i.e., TGE) |
| 224.1 | DF | .~.~ Rhabdoviridae (e.g., rabies virus, vesicular stomatitis virus, etc.) |
| 225.1 | DF | .~.~ Hepatitis virus (e.g., infectious canine hepatitis virus, duck hepatitis virus, mouse hepatitis virus, etc.) |
| 226.1 | DF | .~.~.~ Hepatitis A virus |
| 227.1 | DF | .~.~.~ Hepatitis B virus (e.g., hepatitis B surface antigen (HBsAg), pre-S region, hepatitis B core antigen (HBcAg), hepatitis B e-antigen, Dane particle, etc.) |
| 228.1 | DF | .~.~.~ Non-A, non-B hepatitis virus or hepatitis C virus |
| 229.1 | DF | .~.~ Herpetoviridae (e.g., herpesvirus, Marek's disease virus, laryngotracheitis virus, infectious bovine rhinotracheitis virus (IBR), infectious pustular vulvovaginitis virus, bovine herpes virus type 1, Aujeszky's disease virus, feline rhinotracheitis virus, feline herpes virus, etc.) |
| 230.1 | DF | .~.~.~ Cytomegalovirus, varicella or herpes zoster virus, or Epstein-Barr virus |
| 231.1 | DF | .~.~.~ Herpes simplex virus (e.g., HSV-1, HSV-2, etc.) |
| 232.1 | DF | .~.~ Poxviridae (e.g., smallpox virus, avian pox virus, fowlpox virus, rabbit myxoma virus, vaccinia virus, etc.) |
| 233.1 | DF | .~.~ Adenoviridae, adeno-like virus, or Parvoviridae (e.g., adenovirus, canine parvovirus, mink enteritis virus, hemorrhagic enteritis virus, feline panleukopenia virus, egg drop syndrome virus, etc.) |
| 234.1 | DF | .~ Bacterium or component thereof or substance produced by said bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, etc.) |
| 235.1 | DF | .~.~ Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
| 236.1 | DF | .~.~ Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
| 237.1 | DF | .~.~.~ Staphylococcus or Streptococcus |
| 238.1 | DF | .~.~.~ Corynebacterium (e.g., Corynebacterium diphtheriae, etc.) |
| 239.1 | DF | .~.~.~ Clostridium (e.g., Clostridium tetani, etc.) |
| 240.1 | DF | .~.~.~ Bordetella (e.g., Bordetella pertussis, etc.) |
| 241.1 | DF | .~.~.~ Escherichia (e.g., Escherichia coli, etc.) |
| 242.1 | DF | .~.~ Pilus, fimbria, or adhesin |
| 243.1 | DF | .~.~ Staphylococcus (e.g., Staphylococcus aureus, etc.) |
| 244.1 | DF | .~.~ Streptococcus (e.g., Group B Streptococcus, pneumococcus or Streptococcus pneumoniae, etc.) |
| 245.1 | DF | .~.~ Corynebacterium (e.g., Corynebacterium diphtheriae, etc.) |
| 246.1 | DF | .~.~ Bacillus |
| 247.1 | DF | .~.~ Clostridium (e.g., Clostridium tetani, Clostridium difficile, Clostridium perfringens, Clostridium botulinum, Clostridium chauvoei, etc.) |
| 248.1 | DF | .~.~ Mycobacterium (e.g., Mycobacterium tuberculosis, Calmette-Guerin bacillus (i.e., BCG), etc.) |
| 249.1 | DF | .~.~ Neisseria (e.g., Neisseria gonorrhoeae, etc.) |
| 250.1 | DF | .~.~.~ Neisseria meningitidis |
| 251.1 | DF | .~.~ Moraxella (e.g., Moraxella bovis, etc.) |
| 252.1 | DF | .~.~ Brucella (e.g., Brucella abortus, Brucella canis, etc.) |
| 253.1 | DF | .~.~ Bordetella (e.g., Bordetella bronchiseptica, etc.) |
| 254.1 | DF | .~.~.~ Bordetella pertussis |
| 255.1 | DF | .~.~ Pasteurella (e.g., Pasteurella multocida, Pasteurella hemolytica, etc.) |
| 256.1 | DF | .~.~ Hemophilus (e.g., Hemophilus influenzae, Hemophilus gallinarum, Hemophilus pleuropnemoniae, etc.) |
| 257.1 | DF | .~.~ Escherichia (e.g., Escherichia coli, etc.) |
| 258.1 | DF | .~.~ Salmonella (e.g., Salmonella typhimurium, etc.) |
| 259.1 | DF | .~.~ Klebsiella (e.g., Klebsiella pneumoniae, etc.) |
| 260.1 | DF | .~.~ Pseudomonas (e.g., Pseudomonas aeruginosa, etc.) |
| 261.1 | DF | .~.~ Vibrio (e.g., Vibrio cholera, etc.) |
| 262.1 | DF | .~.~ Treponema (e.g., Treponema hyodysenteriae, Treponema pallidum, etc.) |
| 263.1 | DF | .~.~ Chlamydia (e.g., Chlamydia trachomatis, etc.) |
| 264.1 | DF | .~.~ Mycoplasma |
| 265.1 | DF | .~ Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., Schistosoma, Dirofilaria, Trichinella, Fasciola, Ancylostoma, Ascaris, etc.) |
| 266.1 | DF | .~.~ Component characterized by molecular weight |
| 267.1 | DF | .~.~.~ Eimeria |
| 268.1 | DF | .~.~.~ Plasmodium |
| 269.1 | DF | .~.~ Parasitic protozoan (e.g., Trypanosoma, Trichomonas, Leishmania, Entamoeba, etc.) |
| 270.1 | DF | .~.~.~ Babesia |
| 271.1 | DF | .~.~.~ Eimeria |
| 272.1 | DF | .~.~.~ Plasmodium |
| 273.1 | DF | .~.~.~ Toxoplasma |
| 274.1 | DF | .~ Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., Trichophyton, etc.) |
| 275.1 | DF | .~ Allergen or component thereof (e.g., ragweed pollen, etc.) |
| 276.1 | DF | .~.~ Characterized by molecular weight |
| 277.1 | DF | .~ Cancer cell or component thereof |
| 278.1 | DF | NONSPECIFIC IMMUNOEFFECTOR, PER SE (E.G., ADJUVANT, NONSPECIFIC IMMUNOSTI- MULATOR, NONSPECIFIC IMMUNOPOTENTIATOR, NONSPECIFIC IMMUNOSUPPRESSOR, NON- SPECIFIC IMMUNOMODULATOR, ETC.); OR NONSPECIFIC IMMUNOEFFECTOR, STABILIZER, EMULSIFIER, PRESERVATIVE, CARRIER, OR OTHER ADDITIVE FOR A COMPOSITION CON- TAINING AN IMMUNOGLOBULIN, AN ANTISERUM, AN ANTIBODY, OR FRAGMENT THEREOF, AN ANTIGEN, AN EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR |
| 279.1 | DF | .~ Synthetic or structurally-modified peptidoglycan or mucopolysaccharide or fragment thereof (e.g., derivative of N-acetyl-muramyl-L-alanyl-D-glutamic or fragment thereof (e.g., derivative of N-acetyl-muramyl-L-alanyl-D- acid, etc.) glutamic acid, etc.) |
| 280.1 | DF | .~ Synthetic polymer or copolymer |
| 281.1 | DF | .~ Virus (e.g., interferon-inducing virus, etc.) |
| 282.1 | DF | .~ Bacterium or component thereof or substance produced by said bacterium |
| 283.1 | DF | .~ Lipid or oil |
| 93.1 | DF | WHOLE LIVE MICRO-ORGANISM, CELL, OR VIRUS CONTAINING |
| 93.2 | DF | .~ Genetically modified micro-organism, cell, or virus (e.g., transformed, fused, hybrid, etc.) |
| 93.21 | DF | .~.~ Eukaryotic cell |
| 93.3 | DF | .~ Intentional mixture of two or more micro-organisms, cells, or viruses of different genera |
| 93.4 | DF | .~ Bacteria or actinomycetales |
| 93.41 | DF | .~.~ Clostridium |
| 93.42 | DF | .~.~ Staphylococcus |
| 93.43 | DF | .~.~ Streptomyces |
| 93.44 | DF | .~.~ Streptococcus |
| 93.45 | DF | .~.~ Lactobacillus or Pediococcus or Leuconostoc |
| 93.46 | DF | .~.~ Bacillus |
| 93.461 | DF | .~.~.~ B. thuringiensis |
| 93.462 | DF | .~.~.~ B. subtilis |
| 93.47 | DF | .~.~ Pseudomonas |
| 93.48 | DF | .~.~ Enterobacteriaceae |
| 93.5 | DF | .~ Fungus |
| 93.51 | DF | .~.~ Yeast |
| 93.6 | DF | .~ Virus or bacteriophage |
| 93.7 | DF | .~ Animal or plant cell |
| 93.71 | DF | .~.~ Leukocyte |
| 93.72 | DF | .~.~ Platelet |
| 93.73 | DF | .~.~ Erythrocyte |
| 94.1 | DF | ENZYME OR COENZYME CONTAINING |
| 94.2 | DF | .~ Multienzyme complexes or mixtures of enzymes |
| 94.21 | DF | .~.~ Pancreatin |
| 94.3 | DF | .~ Stabilized enzymes or enzymes complexed with nonenzyme (e.g., liposomes, etc.) |
| 94.4 | DF | .~ Oxidoreductases (1. ) (e.g., catalase, dehydrogenases, reductases, etc.) |
| 94.5 | DF | .~ Transferases (2. ), Lyase (4.), Isomerase (5.), Ligase (6.) |
| 94.6 | DF | .~ Hydrolases (3. ) (e.g., urease, lipase, asparaginase, muramidase, etc.) |
| 94.61 | DF | .~.~ Acting on glycosyl compound (3.2) (e.g., glycosidases lysozyme, nucleosidases, cellulase, etc.) |
| 94.62 | DF | .~.~.~ Hyaluronidase or mucinase (3.2.1.35, 3.2.1.36) |
| 94.63 | DF | .~.~ Acting on peptide bonds (3.4) (e.g., urokinease, etc.) |
| 94.64 | DF | .~.~.~ Serene proteinases (3.4.21) (e.g., trypsin, chymotrypsin, plasmin, thrombin, elastase, kallikrein, fibrinolysin, streptokinease, etc.) |
| 94.65 | DF | .~.~.~ SH-proteinases (3.4.22) (e.g., papain, chymopapain, bromelains, ficin, etc.) |
| 94.66 | DF | .~.~.~ Acid proteinases (3.4.23) (e.g., pepsin, renin, chymosin, etc.) |
| 94.67 | DF | .~.~.~ Metalloproteinases (3.4.24) (e.g., collagenase, snake venom zinc proteinase, etc.) |
| 520 | DF | EXTRACT, BODY FLUID, OR CELLULAR MATERIAL OF UNDETERMINED CONSTITUTION DERIVED FROM ANIMAL IS ACTIVE INGREDIENT |
| 522 | DF | .~ Separated animal oil or solidified form thereof derived from animal flesh and other than from liver or dairy type |
| 523 | DF | .~.~ Fish oil or solidified form thereof |
| 524 | DF | .~.~ Whale or porpoise oil or solidified form thereof |
| 525 | DF | .~.~ Skunk, musk, or mink oil or solidified form thereof |
| 526 | DF | .~.~ Lard, rind, or tallow |
| 528 | DF | .~ Bile, bile acid, bile salt, amniotic fluid, or ascitic fluid |
| 529 | DF | .~ Blood |
| 530 | DF | .~.~ Plasma |
| 531 | DF | .~.~ Serum |
| 532 | DF | .~.~ Platelet |
| 533 | DF | .~.~ Erythrocyte |
| 534 | DF | .~.~ Leucocyte |
| 535 | DF | .~ Milk or colostrum (e.g., butter, whey, etc.) |
| 537 | DF | .~ Body fluid or exudate or transudate other than snake venom, feces, urine, or semen (e.g., lymph, saliva, honey, royal jelly, digestive juice, etc.) |
| 538 | DF | .~ Derived from arthropod (e.g., insect, spider, crustacea, etc.) |
| 539 | DF | .~.~ Bee |
| 541 | DF | .~.~ Cantharide |
| 542 | DF | .~ Derived from snake (e.g, venom, etc.) |
| 543 | DF | .~ Waste or feces (e.g., slaughterhouse offal, chicken feet, horn, hair, hide, urine, etc.) |
| 545 | DF | .~.~ Urine |
| 546 | DF | .~.~.~ Sex hormone |
| 547 | DF | .~ Derived from mollusk |
| 548 | DF | .~ Derived from musculoskeletal system, other than cardiac muscle (e.g., cartilage, muscle, etc.) |
| 549 | DF | .~.~ Skeleton (e.g., bone, teeth, etc.) |
| 550 | DF | .~ Digestive system (e.g., salivary gland, etc.) |
| 551 | DF | .~.~ Gastrointestinal system (e.g., intestine, stomach, gall bladder, etc.) |
| 553 | DF | .~.~.~ Liver |
| 554 | DF | .~.~.~.~ Fish liver oil or solidified form thereof |
| 555 | DF | .~.~.~.~.~ Cod liver oil or solidified form thereof |
| 556 | DF | .~.~.~ Pancreas |
| 557 | DF | .~ Respiratory system (e.g., lung, etc.) |
| 558 | DF | .~ Urogenital system (e.g., kidney, etc.) |
| 559 | DF | .~.~ Genitalia (e.g., ovary, uterus, prostate, testis, etc.) |
| 561 | DF | .~.~ Germ cell (e.g., ovum, spermatozoa, etc.) |
| 562 | DF | .~ Endocrine system, other than the thymus gland (e.g., parathyroid gland, etc.) |
| 563 | DF | .~.~ Adrenal gland |
| 565 | DF | .~.~ Pituitary gland |
| 568 | DF | .~.~ Thyroid gland |
| 569 | DF | .~ Cardiovascular system, other than umbilical artery or vein (e.g., blood vessel, heart, cardiac muscle, etc.) |
| 570 | DF | .~ Nervous system (e.g., brain, nerve, etc.) |
| 571 | DF | .~ Sense organ (e.g., eye, taste bud, etc.) |
| 572 | DF | .~ Tissue, other than lymphoid tissue (e.g., connective, etc.) |
| 573 | DF | .~.~ Neoplastic, tumor, or cancer |
| 574 | DF | .~.~ Adipose or epithelium |
| 577 | DF | .~ Hemic or immune system (e.g., hematopoietic system, bone marrow cells, etc.) |
| 578 | DF | .~.~ Lymphoid tissue (e.g., adenoid, lymph node, etc.) |
| 579 | DF | .~.~.~ Spleen |
| 580 | DF | .~.~.~ Thymus gland |
| 581 | DF | .~ Egg enclosed in shell or a part thereof (e.g., eggshell, egg yolk, etc.) |
| 582 | DF | .~ Embryonic structure (e.g., embryo or fetus, etc.) |
| 583 | DF | .~.~ Placenta or umbilical cord |
| 114 | DF | PLURAL FERMENTATES OF DIFFERENT ORIGIN (E.G., MIXTURES OF ANTIBIOTICS, ETC.) |
| 115 | DF | FERMENTATE OF UNKNOWN CHEMICAL STRUCTURE |
| 116 | DF | .~ Having a known elemental analysis (e.g., antibiotic, etc.) |
| 117 | DF | .~.~ Sulfur containing |
| 118 | DF | .~.~ 45-55% carbon |
| 119 | DF | .~.~ Over 55 to 58% carbon |
| 120 | DF | .~.~ Over 58 to 60% carbon |
| 121 | DF | .~.~ Over 60 to 62% carbon |
| 122 | DF | .~.~ Over 62% carbon |
| 123 | DF | .~ Processes of making, purifying or recovering (nonfermentation) |
| 124 | DF | .~.~ Ion exchange or chromatography |
| 125 | DF | FREE CARBON CONTAINING |
| 126 | DF | WITH CORROSION INHIBITOR |
| 600 | DF | INORGANIC ACTIVE INGREDIENT CONTAINING |
| 601 | DF | .~ Phosphorus or phosphorus compound |
| 602 | DF | .~.~ Calcium containing |
| 603 | DF | .~.~.~ Pyrophosphate |
| 604 | DF | .~.~ Heavy metal containing |
| 605 | DF | .~.~ Phosphorus acid |
| 606 | DF | .~.~ Sodium containing or fluorine containing |
| 607 | DF | .~ Hydrogen metal cyanide, cyanide, cyanate, or thio analog thereof |
| 608 | DF | .~.~ Heavy metal containing (e.g., nitroprusside, etc.) |
| 609 | DF | .~.~.~ Thiocyanates |
| 610 | DF | .~.~ Potassium or lithium containing |
| 611 | DF | .~.~ Sodium containing |
| 612 | DF | .~.~ Hydrocyanic acid |
| 613 | DF | .~ Peroxide or compositions of or releasing gaseous oxygen or ozone |
| 614 | DF | .~.~ Zinc containing |
| 615 | DF | .~.~ Sodium containing |
| 616 | DF | .~.~ Hydrogen peroxide |
| 617 | DF | .~ Heavy metal or compound thereof |
| 618 | DF | .~.~ Silver |
| 619 | DF | .~.~.~ Nitrite |
| 620 | DF | .~.~ Arsenic |
| 621 | DF | .~.~.~ With elemental arsenic or arsenic containing compound |
| 622 | DF | .~.~.~ Copper compound of arsenic |
| 623 | DF | .~.~.~ Oxygen compound of arsenic |
| 624 | DF | .~.~.~ Sodium compound of arsenic |
| 625 | DF | .~.~.~ Manganese containing arsenic compound or with added manganese compound |
| 626 | DF | .~.~.~ Chromium containing arsenic compound or with added chromium compound |
| 627 | DF | .~.~.~ Lead compound of arsenic |
| 628 | DF | .~.~.~ Calcium compound of arsenic |
| 629 | DF | .~.~.~ With added organic compound |
| 630 | DF | .~.~ Copper |
| 631 | DF | .~.~.~ With cellulose-sulfur compound or lignin |
| 632 | DF | .~.~.~ Halogen containing |
| 633 | DF | .~.~.~ Hydroxide |
| 634 | DF | .~.~.~ Carbonate |
| 635 | DF | .~.~.~ Oxide |
| 637 | DF | .~.~.~ Sulfur containing |
| 638 | DF | .~.~.~ With added organic compound |
| 639 | DF | .~.~ Manganese |
| 640 | DF | .~.~.~ Potassium permanganate |
| 641 | DF | .~.~ Zinc |
| 642 | DF | .~.~.~ For topical application |
| 643 | DF | .~.~.~ Orally assimilable or injectable composition |
| 644 | DF | .~.~ Mercury |
| 645 | DF | .~.~.~ Chlorine containing |
| 646 | DF | .~.~ Iron, cobalt, nickel, vanadium, molybdenum, or palladium |
| 647 | DF | .~.~.~ Ferric |
| 648 | DF | .~.~.~ Ferrous |
| 649 | DF | .~.~ Gold or platinum |
| 650 | DF | .~.~ Tin, gallium, germanium, indium, or tellurium |
| 651 | DF | .~.~ Antimony |
| 652 | DF | .~.~ Lead |
| 653 | DF | .~.~ Bismuth |
| 654 | DF | .~.~ Cadmium |
| 655 | DF | .~.~ Chromium |
| 656 | DF | .~.~.~ Potassium dichromate |
| 657 | DF | .~ Boron |
| 658 | DF | .~.~ Borax |
| 659 | DF | .~.~ Boric acid |
| 660 | DF | .~.~ Borates |
| 661 | DF | .~ Elemental chlorine or elemental chlorine releasing inorganic compound (e.g., chlorties, hypochlorites, etc.) |
| 662 | DF | .~.~ Chlorate |
| 663 | DF | .~.~ Chloride |
| 664 | DF | .~.~.~ Ammonium chloride |
| 665 | DF | .~.~ Alkali metal or alkaline earth metal |
| 666 | DF | .~ Hydrochloric acid |
| 667 | DF | .~ Elemental iodine or iodine compound |
| 668 | DF | .~.~ Iodate |
| 669 | DF | .~.~ Iodide |
| 670 | DF | .~.~.~ Potassium iodide |
| 671 | DF | .~.~.~ Sodium iodide |
| 672 | DF | .~.~ Iodophors |
| 673 | DF | .~ Elemental fluorine or fluorine compound |
| 674 | DF | .~.~ Silicofluoride |
| 675 | DF | .~.~ Calcium containing |
| 676 | DF | .~.~ Sodium containing |
| 677 | DF | .~ Alkali or alkaline earth chloride (e.g., barium or lithium chloride, etc.) |
| 678 | DF | .~.~ Calcium chloride |
| 679 | DF | .~.~ Potassium chloride |
| 680 | DF | .~.~ Sodium chloride |
| 681 | DF | .~.~ Magnesium chloride |
| 682 | DF | .~ Aluminum, calcium or magnesium element, or compound containing |
| 683 | DF | .~.~ Magnesium silicate |
| 684 | DF | .~.~ Aluminum silicate |
| 685 | DF | .~.~ Aluminum chloride or bromide |
| 686 | DF | .~.~ Carbonate or bicarbonate |
| 687 | DF | .~.~.~ Calcium carbonate |
| 688 | DF | .~.~ Oxide or hydroxide |
| 689 | DF | .~.~.~ With stabilizer or suspending agent |
| 690 | DF | .~.~.~ Aluminum hydroxide |
| 691 | DF | .~.~.~ Aluminum oxide |
| 692 | DF | .~.~.~ Magnesium hydroxide or oxide |
| 693 | DF | .~.~.~ Calcium hydroxide |
| 694 | DF | .~.~.~.~ Characterized as lime or slaked lime |
| 695 | DF | .~.~.~ Lime-sulfur |
| 696 | DF | .~.~ Calcium containing sulfur compound (e.g., calcium sulfate, etc.) |
| 697 | DF | .~.~.~ Magnesium sulfate (e.g., epson salts, etc.) |
| 698 | DF | .~.~ Alum or burnt alum |
| 699 | DF | .~ Carbon disulfide, monoxide, or dioxide |
| 700 | DF | .~.~ Carbon dioxide |
| 701 | DF | .~.~ Carbon disulfide |
| 702 | DF | .~ Selenium or compound thereof |
| 703 | DF | .~ Elemental sulfur or compound thereof |
| 704 | DF | .~.~ With organic silicones material |
| 705 | DF | .~.~ Sulfur, per se |
| 706 | DF | .~.~ Sulfide |
| 707 | DF | .~.~.~ Disulfides |
| 708 | DF | .~.~.~ Hydrogen sulfide |
| 709 | DF | .~.~ Sulfate |
| 710 | DF | .~.~.~ Ammonium sulfate |
| 711 | DF | .~.~ Sulfites or thiosulfates |
| 712 | DF | .~.~ Sulfur dioxide |
| 713 | DF | .~.~ With added organic compound |
| 714 | DF | .~.~.~ Plant extract of undetermined constitution |
| 715 | DF | .~ Carbonate |
| 716 | DF | .~.~ Ammonium carbonate |
| 717 | DF | .~.~ Bicarbonate |
| 718 | DF | .~ Nitrates or nitrites or nitric acid or nitrogen oxides |
| 719 | DF | .~ Ammonia or ammonium compound containing |
| 720 | DF | .~.~ Ammonium chloride |
| 721 | DF | .~.~ Aqueous ammonia containing |
| 722 | DF | .~ Alkali metal or alkaline earth containing |
| 723 | DF | .~ Elemental bromine or bromine compound containing |
| 724 | DF | .~ Silicon dioxide containing |
| 195.1 | DF | PLANT EXTRACT OR PLANT MATERIAL OF UNDETERMINED CONSTITUTION |
| 196.1 | DF | .~ Pine oil, tar, gum, or resin. |
| 197.1 | DF | .~ Tobacco or tobacco extract |
| ****************************** | ||
| *CLASS 514 IS AN INTEGRAL....* | ||
| *PART OF CLASS 424 AS SHOWN..* | ||
| *BY THE POSITION OF THIS BOX.* | ||
| *IT PROVIDES FOR.............* | ||
| *PHARMACEUTICAL COMPOSITION..* | ||
| *AND PROCESSES HAVING........* | ||
| *DESIGNATED ORGANIC ACTIVE...* | ||
| *INGREDIENTS CHARACTERIZED...* | ||
| *BY THIS STRUCTURE. .........* | ||
| ****************************** | ||
| ****************************** | ||
| CROSS-REFERENCE ART COLLECTIONS RELATED TO SUBCLASSES 130.1 THROUGH 283.1 | ||
| ****************************** | ||
| 800 | DF | ANTIBODY OR FRAGMENT THEREOF WHOSE AMINO ACID SEQUENCE IS DISCLOSED IN WHOLE OR IN PART |
| 801 | DF | INVOLVING ANTIBODY OR FRAGMENT THEREOF PRODUCED BY RECOMBINANT DNA TECHNOLOGY |
| 802 | DF | ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF THAT BINDS GRAM-POSITIVE BACTERIA |
| 803 | DF | ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF THAT BINDS GRAM-NEGATIVE BACTERIA |
| 804 | DF | INVOLVING IgG3, IgG4, IgA, OR IgY |
| 805 | DF | INVOLVING IgE or IgD |
| 806 | DF | INVOLVING IgM |
| 807 | DF | .~ Monoclonal |
| 808 | DF | .~.~ Human |
| 809 | DF | INVOLVING IMMUNOGLOBULIN OR ANTIBODY FRAGMENT (E.G., F(ab')2, Fab', Fv, Fc, HEAVY CHAIN, LIGHT CHAIN, ETC.) |
| 810 | DF | INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, IMMUNOTOLERANCE, OR ANERGY |
| 811 | DF | INVOLVING SEX SELECTION OR CONTRACEPTION |
| 812 | DF | LIPOSOME COMPRISING AN ANTIBODY, ANTIBODY FRAGMENT, ANTIGEN, OR OTHER SPECIFIC OR NONSPECIFIC IMMUNOEFFECTOR |
| 813 | DF | VIRAL VACCINE FOR BOVINE SPECIES (E.G., CATTLE, ETC.) |
| 814 | DF | VIRAL VACCINE FOR OVINE SPECIES (E.G., SHEEP, ETC.) |
| 815 | DF | VIRAL VACCINE FOR PORCINE SPECIES (E.G., SWINE, ETC.) |
| 816 | DF | VIRAL VACCINE FOR AVIAN SPECIES (E.G., POULTRY OR OTHER BIRDS, ETC.) |
| 817 | DF | VIRAL VACCINE FOR FISH |
| 818 | DF | VIRAL VACCINE FOR CANIDAE OR MUSTELIDAE (E.G., DOGS, FOXES, MINKS, ETC.) |
| 819 | DF | VIRAL VACCINE FOR FELINE SPECIES (E.G., CATS, ETC.) |
| 820 | DF | VIRAL VACCINE FOR EQUINE SPECIES (E.G., HORSES, ETC.) |
| 821 | DF | INVOLVING TEMPERATURE-SENSITIVE MUTANT VIRUS |
| 822 | DF | INVOLVING TK- VIRUS |
| 823 | DF | BACTERIAL VACCINE FOR BOVINE SPECIES (E.G., CATTLE, ETC.) |
| 824 | DF | BACTERIAL VACCINE FOR OVINE SPECIES (E.G., SHEEP, ETC.) |
| 825 | DF | BACTERIAL VACCINE FOR PORCINE SPECIES (E.G., SWINE, ETC.) |
| 826 | DF | BACTERIAL VACCINE FOR AVIAN SPECIES (E.G., POULTRY OR OTHER BIRDS, ETC.) |
| 827 | DF | BACTERIAL VACCINE FOR FISH |
| 828 | DF | BACTERIAL VACCINE FOR CANIDAE OR MUSTELIDAE (E.G., DOGS, FOXES, MINKS, ETC.) |
| 829 | DF | BACTERIAL VACCINE FOR EQUINE SPECIES (E.G., HORSES, ETC.) |
| 830 | DF | INVOLVING TEMPERATURE-SENSITIVE MUTANT BACTERIUM |
| 831 | DF | INVOLVING CAPSULAR POLYSACCHARIDE OF BACTERIUM (E.G., POLYRIBOSYL RIBITOL PHOSPHATE (PRP), ETC.) |
| 832 | DF | INVOLVING BACTERIAL TOXIN THAT HAS MODIFIED AMINO ACID SEQUENCE |
| ********************************* | ||
| Cross Reference Art Collection Relating to subclasses 9.1 through 10.4 | ||
| ********************************* | ||
| 900 | DF | IN VIVO DIAGNOSTIC OR IN VIVO TEST AGENT WHICH CONTAINS AN ADDITIONAL INGREDIENT TO REDUCE THE TOXICITY OR SIDE EFFECTS OF THE ACTIVE INGREDIENT |
| ****************************** | ||
| DIGESTS | ||
| ****************************** | ||
| DIG 1 | DD | Aerosol hair preparation |
| DIG 2 | DD | Resin hair settings |
| DIG 3 | DD | Hair bleach |
| DIG 4 | DD | Dandruff |
| DIG 5 | DD | Stick |
| DIG 6 | DD | Chelate |
| DIG 7 | DD | Microporous membranes |
| DIG 8 | DD | Systemic pesticides |
| DIG 9 | DD | Fish posts |
| DIG 10 | DD | Insect repellent |
| DIG 11 | DD | Termite treating |
| DIG 12 | DD | Fertilization attaching inhibition |
| DIG 13 | DD | Burn treatment |
| DIG 14 | DD | Topical contraceptives and spermacides |
| DIG 15 | DD | Suppositories |
| DIG 16 | DD | Dendrimers and dendritic polymers |